Lonza Group has acquired the entire share capital of Micro-Macinazione SA, one of Europe’s leading contract manufacturers providing micronisation of active ingredients for the pharmaceutical and fine chemical industries.
Micro-Macinazione had sales of CHF20m in 2016. Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets.
Bär & Karrer acted as legal adviser to Lonza Group in this transaction. The team included Paolo Bottini and Edoardo Buzzi (M&A).